Vibra-Tabs

Rocky Mountain Spotted Fever, Acinetobacter Infections, Ureaplasma Infections + 61 more
Treatment
93 FDA approvals
18 Active Studies for Vibra-Tabs

What is Vibra-Tabs

DoxycyclineThe Generic name of this drug
Treatment SummaryDoxycycline is a type of antibiotic used to treat bacterial infections. It is derived from oxytetracycline and is less toxic than other types of tetracycline antibiotics. Doxycycline can be used to treat a wide variety of bacterial infections, depending on the results of a laboratory test.
Vibramycin Hyclateis the brand name
Vibra-Tabs Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Vibramycin Hyclate
Doxycycline
1967
728

Approved as Treatment by the FDA

Doxycycline, otherwise known as Vibramycin Hyclate, is approved by the FDA for 93 uses such as Streptococcus Pneumoniae Infections and Chlamydia Infections .
Streptococcus Pneumoniae Infections
Chlamydia Infections
Campylobacter Infections
Inclusion conjunctivitis
Chlamydia Infections
Urethritis
Clostridium difficile Infection
Typhus, Endemic Flea-Borne
Communicable Diseases
Brucellosis
Used to treat Brucellosis in combination with Streptomycin
Yersinia pestis
Infection Due to Escherichia Coli
Chlamydial Urethritis
Trachoma
Dysentery, Bacillary
Gonorrhea
Bartonella Infections
Acne Vulgaris
Q Fever
Acinetobacter Infections
Ureaplasma Infections
Plague
Communicable Diseases
Uterine Cervicitis
Tularemia
Upper Respiratory Tract Infection
Malaria
Relapsing Fever
Amebic colitis
Bartonella bacilliformis infections
Ureaplasma Infections
Skin Infections
Primary Syphilis
Bacteriological Techniques
Listeria infection
Typhus infections
Anal chlamydia infection
Plasmodium Infections
Pneumococcal Infections
Yaws
Staphylococcus (S.) Aureus Infection
Chlamydia trachomatis
Genus Chlamydia
Recurrent Upper and Lower Respiratory Tract Infections (RTIs)
Calymmatobacterium granulomatis
Clostridium Infections
Chlamydia trachomatis
Common Cold
Haemophilus Influenzae Infections
Actinomycosis
Brucellosis
Used to treat Brucellosis in combination with Streptomycin
Relapsing fever caused by Borrelia recurrentis
Secondary Syphilis
Rickettsialpox
Necrotizing ulcerative gingivostomatitis
Klebsiella Infections
Campylobacter Infection
Lymphogranuloma Venereum
Intestinal Amebiasis
Cholera (Disorder)
Urinary Tract Infections
Communicable Diseases
Mycoplasma Pneumoniae
Shigella Infection
Trachoma
Severe Acne
Epididymo-orchitis gonococcal
Chancroid
Tick-borne fever
Rocky Mountain Spotted Fever
Fever
Acinetobacter Infections
Bacterial Infection caused by Enterobacter aerogenes
Psittacosis
Neisseria Gonorrhoeae Infection
Chlamydia psitacci infection
Cat-Scratch Disease
Trachoma inclusion conjunctivitis
inhaled anthrax caused by Bacillus anthracis
Plague
Ureaplasma urethritis
Urethritis
Chlamydial cervicitis
Listeriosis
Yaws
Relapsing Fever
Vibrio Cholerae Infection
Disease
Haemophilus ducreyi infection
Tularemia
prophylaxis of Malaria
Respiratory Tract Infections
Granuloma Inguinale

Effectiveness

How Vibra-Tabs Affects PatientsDoxycycline and other tetracyclines are drugs that inhibit the growth of bacteria and stop them from multiplying. They work by preventing bacteria from making proteins needed to survive. Doxycycline is a highly lipophilic drug, meaning it can penetrate the cells of target molecules. It has a wide range of uses, including treating bacterial infections, parasites, and inflammation. Studies have found it to be effective in treating skin conditions like bullous dermatoses and rosacea.
How Vibra-Tabs works in the bodyDoxycycline stops bacteria from making essential proteins they need to survive. It does this by blocking the connection between molecules that carry amino acids and certain parts of the bacterial cell. It also helps reduce inflammation by stopping the growth of specific cells and preventing the production of a signaling molecule that causes inflammation.

When to interrupt dosage

The encouraged dosage of Vibra-Tabs is subject to the diagnosed condition, including Urethritis, Chlamydia trachomatis and Respiratory Tract Infections. The measure of dosage is contingent upon the delivery approach (e.g. Capsule or Syrup - Oral) denoted in the table underneath.
Condition
Dosage
Administration
Inclusion conjunctivitis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Dysentery, Bacillary
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Disease
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Listeriosis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Pneumococcal Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Common Cold
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Communicable Diseases
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Lymphogranuloma Venereum
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Granuloma Inguinale
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Malaria
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Haemophilus Influenzae Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Chlamydia trachomatis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Relapsing Fever
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Genus Chlamydia
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Chlamydia Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Ureaplasma Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Rickettsialpox
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
inhaled anthrax caused by Bacillus anthracis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Urinary Tract Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Urethritis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous

Warnings

Vibra-Tabs has three contraindications, and its usage should be avoided in combination with any of the conditions listed in the following table.Vibra-Tabs Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Doxycycline may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Doxycycline may interact with Pulse Frequency
There are 20 known major drug interactions with Vibra-Tabs.
Common Vibra-Tabs Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Doxycycline.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Doxycycline.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Doxycycline.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Doxycycline.
Amdinocillin
Major
The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Doxycycline.
Vibra-Tabs Toxicity & Overdose RiskThe toxic dose of doxycycline for rats is 2000mg/kg, for mice it is 1870mg/kg, and for dogs it is 500mg/kg. If someone overdoses on doxycycline, they should stop taking the drug and receive medical attention. Dialysis will not help reduce the amount of doxycycline in the bloodstream.

Vibra-Tabs Novel Uses: Which Conditions Have a Clinical Trial Featuring Vibra-Tabs?

34 active clinical trials are currently assessing the potential of Vibra-Tabs to mitigate Haemophilus Influenzae Infections, Respiratory Tract Infections and Amebic colitis.
Condition
Clinical Trials
Trial Phases
Trachoma
1 Actively Recruiting
Phase 4
inhaled anthrax caused by Bacillus anthracis
0 Actively Recruiting
Pneumococcal Infections
0 Actively Recruiting
Chlamydia Infections
0 Actively Recruiting
Klebsiella Infections
0 Actively Recruiting
Tularemia
0 Actively Recruiting
Actinomycosis
0 Actively Recruiting
Inclusion conjunctivitis
0 Actively Recruiting
Malaria
0 Actively Recruiting
Chlamydia trachomatis
3 Actively Recruiting
Phase 2, Not Applicable
Chancroid
0 Actively Recruiting
Plague
0 Actively Recruiting
Epididymo-orchitis gonococcal
0 Actively Recruiting
Plague
0 Actively Recruiting
Urinary Tract Infections
2 Actively Recruiting
Not Applicable
Chlamydia trachomatis
0 Actively Recruiting
Ureaplasma Infections
0 Actively Recruiting
Uterine Cervicitis
0 Actively Recruiting
Urethritis
0 Actively Recruiting
Gonorrhea
0 Actively Recruiting

Vibra-Tabs Reviews: What are patients saying about Vibra-Tabs?

5Patient Review
3/22/2012
Vibra-Tabs for Acne
This treatment cleared up my acne and I'm really happy with the results.

Patient Q&A Section about vibra-tabs

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of Vibra?

"... , unusual tiredness or weakness.

If you have any of the following symptoms, you may be experiencing an allergic reaction: bloating, chills, coughing, dark urine, diarrhea, difficulty with swallowing, fever, headache, hives or welts, itching, or rash. Additional symptoms include increased thirst, nausea, pain in the stomach, side, or abdomen, possibly radiating to the back, sore throat, unusual tiredness or weakness."

Answered by AI

What is Vibra tab used for?

"This medication is used to treat a wide variety of bacterial infections by stopping the growth of bacteria. It is also used to prevent malaria."

Answered by AI

What drug class is Vibra-tabs?

"Doxycycline is a tetracycline antibiotic that helps to kill bacteria or prevent their growth."

Answered by AI

Clinical Trials for Vibra-Tabs

Have you considered Vibra-Tabs clinical trials? We made a collection of clinical trials featuring Vibra-Tabs, we think they might fit your search criteria.
Have you considered Vibra-Tabs clinical trials? We made a collection of clinical trials featuring Vibra-Tabs, we think they might fit your search criteria.
Have you considered Vibra-Tabs clinical trials? We made a collection of clinical trials featuring Vibra-Tabs, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top